Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients

Published:2023-11 Issue:11 Volume:9 Page:e21906
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Ren Tianying,Hou Xu,Zhang Xin,Chen Dongliang,Li Juan,Zhu Yingnan,Liu Zhiheng,Yang Dawei^ORCID

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference40 articles.

1. Cancer statistics in China and United States, 2022: profiles, trends, and determinants;Xia;Chin. Med. J.,2022

2. Cancer situation in China: what does the China cancer map indicate from the first national death survey to the latest cancer registration?;Feng;Cancer Commun.,2023

3. Validation of the galad model for early diagnosis and monitoring of hepatocellular carcinoma in Chinese multicenter study;Huang;Liver Int.,2022

4. Asap score versus galad score for detection of hepatitis c-related hepatocellular carcinoma: a multicenter case-control analysis;Liu;Front. Oncol.,2022

5. Global burden of primary liver cancer in 2020 and predictions to 2040;Rumgay;J. Hepatol.,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular carcinoma imaging: Exploring traditional techniques and emerging innovations for early intervention;Medicine in Novel Technology and Devices;2024-12

2. Alpha-fetoprotein: Past, present, and future;Hepatology Communications;2024-04-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP